Schedule 13G ownership disclosure

Lexeo Therapeutics Inc

Common Shares · CUSIP: 52886X107

Event date: 2024-12-31

Filing-level shares
1,926,331
Percent of class
5.8%
  • Mizuho Financial Group, Inc.

    Shares: 1,926,331 · Class: 5.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-25-019457
Form type
SCHEDULE 13G
Filer
Lexeo Therapeutics, Inc.
CIK
CIK 1907108
Filed
Feb 13, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub